Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Lidia Fonseca is Director at Pfizer. OQRO lists 8 transactions filed with the SEC under this name, the latest on Nov 2, 2026, each linked to the official Form 4.
Director
Disclosures on record
8
Companies involved
3
Lidia Fonseca has no open-market purchase on record since 2010. Sales in 2 of the 17 years since 2010.
Lidia Fonseca reported 0 open-market purchases and 4 sales since 2010; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2012 | — | $1.88M2×2 trades |
| 2010 | — | $23K2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Nov 1, 2026650disclosed Nov 2
DetailsOfficial recordMedtronicMDT
2 disclosures · Apr 2026
Apr 27, 20262,111disclosed Apr 30
DetailsOfficial recordApr 28, 2026207disclosed Apr 30
DetailsOfficial recordPfizerPFE
5 disclosures · Feb 2026 – Mar 2026
Mar 3, 202682Kdisclosed Mar 5
DetailsOfficial recordFeb 25, 202657Kdisclosed Feb 27
DetailsOfficial recordFeb 25, 202657Kdisclosed Feb 27
DetailsOfficial recordFeb 25, 202654Kdisclosed Feb 27
DetailsOfficial recordFeb 25, 20261,058disclosed Feb 27
DetailsOfficial recordAs of the latest filing on , Lidia Fonseca reported holding 46,455 shares of Pfizer (PFE), worth about $1.3M at the last close of $28 (Nov 18, 2026). Holdings are also on file at Medtronic (MDT); together they are worth about $2.07M.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Pfizer PFE | 46,455 | 46K direct | $28 | $1.3M | Feb 25, 2026 |
| Medtronic MDT | 7,644 | 7,644 direct | $101 | $770K | Apr 28, 2026 |
Is this Lidia Fonseca’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Lidia Fonseca reported 0 open-market purchases and 4 sales here, 2010 to 2012.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Feb 25, 2026, Lidia Fonseca reported holding 46,455 shares of Pfizer (PFE). At the last close of $28 on Nov 18, 2026, that is about $1.3M. This is the stake disclosed in filings, not a net worth.
No public filing gives Lidia Fonseca's net worth. What SEC Form 4 shows is the stock stake: 46,455 shares of Pfizer (PFE), about $1.3M at the last close, plus holdings in 1 other company, about $2.07M in all. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Lidia Fonseca has no open-market purchase on record since 2010. Sales in 2 of the 17 years since 2010.
In SEC filings since 2010: no open-market purchase is on record; the latest open-market sale is from 2012.
Labcorp (LH), from 2010 to 2012: 0 purchases and 4 sales.